State Price Transparency Reporting (SPTR) has rapidly evolved from an occasional filing obligation into a core compliance and operational responsibility for pharmaceutical manufacturers. With more than 20 states actively enforcing reporting requirements, and additional legislation emerging, manufacturers face increasing risk tied to missed triggers, inconsistent data, and cross‑functional misalignment.
In this on‑demand webinar, Medispend experts Katie Johnson, Senior Director, Revenue Management and Kristin Rademacher, Manager, State Price Transparency Reporting, explore how SPTR enforcement is maturing, where manufacturers are most likely to encounter compliance challenges, and what practical steps organizations can take to strengthen governance, monitoring, and reporting defensibility.
This session covers:
- Why SPTR now demands ongoing, proactive oversight
- How state‑specific triggers and thresholds create hidden risk
- Common causes of late or incomplete reporting
- Practical strategies to improve operational readiness and reduce exposure
Watch the recording to gain clarity on today’s SPTR landscape and prepare for what’s coming next.